The Medtechy Daily: December 3, 2018
Posted on December 03, 2018 by Medtech[y] Staff
The Medtechy Daily provides the latest news and insight for the medical technology industry, including medical device, biotech and digital health.
Tweet of the Day
We have been working hard on this - and it’s only going to get better! https://t.co/MtGjmhMO8B— Donald J. Trump (@realDonaldTrump) November 29, 2018
CVS Completes $70 Billion Acquisition of Aetna. CVS Health Corp. CVS -0.50% completed its nearly $70 billion acquisitionof Aetna Inc.,forging a new industry giant and starting the clock ticking on ambitious goals of curbing health-care costs and improving consumers’ experience. (WSJ)
Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London. Novartis is joining the migration of the major players directly into the heart of the world’s biggest biotech R&D hubs. (Endpoints)
A Simple Way to Map Out Your Career Ambitions. It’s easy to be confused about how to grow in your career. My experience with even the most successful global companies is that they’re between average and poor at developing future talent. They’re often not transparent about your real needs and vague about the most effective development options. (HBR)
Boston Startup Aims To Change How Primary Care Is Done In America. When it comes to your health, forewarned is forearmed, yet the nation’s health care system often struggles with providing the kind of preventative care that can fend off chronic diseases like diabetes. (Forbes Health)
Boston Scientific sues Micro-Tech over endo clip patents. Boston Scientific has filed a lawsuit against Micro-Tech USA and its Chinese manufacturer, Micro-Tech Nanjing, alleging that Micro-Tech infringed three of its patents for endoscopic hemostatic clips. (MassDevice)
AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023. AbbVie is on a hot streak striking patent deals to protect its top drug, Humira. Even as Boehringer Ingelheim has opted to fight the company’s patent claims in court, Pfizer has decided it’s in its own best interest to settle on a late 2023 biosimilar launch date. (FiercePharma)
We're just getting caught back up on the Medtechy Daily and are linking our most recent articles in case you've missed them.
Are Medical Device Reps Wearing Out Their Welcome? An interesting article was posted to our forums earlier this week which questions the need and usefulness of medical device sales reps in the operating room.
Georgia ENT Practice to Pay $1.2 Million to Resolve False Claims Act Allegations. We were alerted to a False Claims Act allegation after the story was posted on our forums earlier this week. According to the FDA press release, the government alleges that Northwest ENT in Georgia violated the False Claims Act.
MedReps' 2019 Best Places to Work in Medical Sales. MedReps announced their annual Best Places to Work in Medical Sales for 2019 and some familiar names sit on top of the list.
Auris Health Announces $220 Million Growth Financing. Auris Health recently announced the close of a $220 million equity financing led by Partner Fund Management. New investors Wellington Management, D1 Capital Partners and Senator Investment Group